Signals, Powered By EquityPandit
Alembic Pharma has received approval for the buyback of equity shares.
The buyback committee of the company has given approval to the buyback of up to 1,02,50,000 equity shares at a price of Rs.80 per share payable in cash, for a total consideration not exceeding Rs.82,00,00,000.
Moreover, the committee has fixed March 23, as the record date for determining the equity shareholders of the company who will be eligible to tender equity shares under the buyback offer.
